Navigation Links
Letter from Alliqua CEO, Dave Johnston, to Shareholders
Date:3/7/2013

NEW YORK, March 7, 2013 /PRNewswire/ -- Alliqua, Inc. (OTCQB: ALQA)

Dear Stockholders,

Two thousand twelve was a year of significant change at Alliqua – change that I firmly believe will set the stage for future growth and success. It was this vision of the future that energized me to join the board of directors and more recently assume the responsibilities as chief executive officer. What I saw was a company with all the necessary building blocks of success:

  • motivated and seasoned management,
  • a proven technology,
  • commercialized and reimbursed products,
  • a U.S. manufacturing facility that can operate at low costs,
  • and a vision to expand into the $20+ billion dollar drug delivery market.

I believe Alliqua has a compelling story that has yet to be told – one that I personally find very exciting. Let's review our 2012 achievements and discuss our plans for future growth.

2012 Achievements: Establishing Strong Leadership and Product Awareness

In the latter part of 2012, we began the first phase of change at Alliqua by bolstering the corporate and medical expertise on our already experienced board of directors through the appointment of Dr. Jerry Zeldis as Chairman. Jerry continues to serve as the chief medical officer of Celgene where, over a 15-year period, he helped build one of the world's most successful publicly traded biotech companies with a current market capitalization in excess of $40 billion. At the same time, I joined the board of directors and then took over as CEO in February of 2013, after having spent the last 25 years operating medical device and wound-care companies. Most recently, I served as the CEO of Convatec Inc., where our team worked to triple overall sales to $1.7 billion, with a large part of those sales derived from the wound care m
'/>"/>

SOURCE Alliqua, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. HealthEconomics.Com Announces Newsletter Promoting Health Outcomes and Pharma Reimbursement Jobs
2. HealthEconomics.Com Presents Top News Stories in Pharma Reimbursement and Pricing from this Week's Newsletter
3. Topical BioMedics' Newsletter Dedicated to Natural Healing and Wellness--New Issue Available Online
4. First Warning Systems and Unicorp Biotech International Strategic Partner Letter of Intent Signed Breast Cancer Early Detection
5. Amarantus BioSciences Issues CEO Letter to Shareholders
6. Mangrove Partners Sends Letter to Stockholders of Nabi Biopharmaceuticals
7. Ronald L. Chez Files Amended 13D and Letter to the Board
8. Elsevier to Participate in SCOAP3 With the Journals Physics Letters B and Nuclear Physics B
9. Bacterin Receives Letter From NYSE MKT LLC Regarding Timely Notice of Record Date for 2012 Annual Meeting of Stockholders
10. Genesis Biopharma Issues Letter To Shareholders
11. NeoStems CEO Letter to Shareholders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... , Aug. 27, 2014 Reportbuyer.com ... The Graphene Opportunity - A Rational View ... Graphene The New Nanotech? A similar amount ... of applications ranging from microelectronics to water treatment, ... announced the availability of the Graphene Opportunity Report, ...
(Date:8/27/2014)... JUNCTION, N.J. , Aug. 27, 2014 ... innovative drug delivery technologies, today announced that it has ... Jersey Business & Industry Association,s 2014 Awards for ... were selected by an independent panel of judges from ... company volunteers. Award winners will be honored at a ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 Remcom announces ... with new features for the biomedical industry. ... enhanced Biological Thermal Sensor, exclusive to the Bio-Pro version ... version of XFdtd, developed to calculate the biological effects ... has been added to all versions to expand engineers’ ...
(Date:8/26/2014)... Bellingham, WA (PRWEB) August 26, 2014 ... visions for next-generation wearable technology, and inspiration for ... highlights at this year’s brighter, busier SPIE ... California, Convention Center. More than 4,400 international scientists, ... conferences, courses, an exhibition, and industry sessions sponsored ...
Breaking Biology Technology:The Graphene Opportunity - A Rational View 2The Graphene Opportunity - A Rational View 3The Graphene Opportunity - A Rational View 4Tris Pharma Selected as an award winner in the New Jersey Business & Industry Association's 2014 Awards for Excellence 2Remcom Announces Enhanced Biological Thermal Sensor and Other Biomedical Features in XFdtd EM Simulation Software Update 2Remcom Announces Enhanced Biological Thermal Sensor and Other Biomedical Features in XFdtd EM Simulation Software Update 3Brighter, Busier SPIE Optics + Photonics Draws International Crowd to San Diego 2Brighter, Busier SPIE Optics + Photonics Draws International Crowd to San Diego 3Brighter, Busier SPIE Optics + Photonics Draws International Crowd to San Diego 4
... Company,s Cancer ... Therapy Product, PITTSBURGH, ... Kathy Blum as the company,s,new Chief Executive Officer. With extensive experience ... global experience with,start-ups and Fortune 500 organizations, Ms. Blum brings 27 ...
... Estate,Equities, Inc. (NYSE: ARE ) today will ... the world on a tour of Green and ... San Diego life,science cluster market. This unique BIO ... Biotechnology Industry Organization,s International,2008 Convention taking place in ...
... 16 Gen-Probe Incorporated,(Nasdaq: GPRO ) announced today ... Company 28th Annual Growth Stock on Wednesday, June 18, ... scheduled to be,webcast live and may be accessed through ... at http://www.gen-probe.com . The webcast will be,available for ...
Cached Biology Technology:Applied Computational Technologies Appoints a New CEO 2Alexandria Real Estate Equities, Inc. Features Green Buildings and Sustainable Operations Initiatives and Tour at 2008 BIO 2Alexandria Real Estate Equities, Inc. Features Green Buildings and Sustainable Operations Initiatives and Tour at 2008 BIO 3Alexandria Real Estate Equities, Inc. Features Green Buildings and Sustainable Operations Initiatives and Tour at 2008 BIO 4Gen-Probe to Webcast Presentation at the William Blair & Company 28th Annual Growth Stock Conference 2
(Date:8/27/2014)... Reportlinker.com announces that a new market ... Law Enforcement Biometrics Market in North America ... About Biometrics Biometrics is a technology that ... their physical or behavioral patterns. It involves the ... as fingerprints, face recognition, DNA, palm print, hand ...
(Date:8/27/2014)... easier when it is related to ability that we ... a new melody more easily than learning how to ... Center for the Neural Basis of Cognition (CNBC)a joint ... Universityhave discovered a fundamental constraint in the brain that ... story in the Aug. 28, 2014, issue of ...
(Date:8/27/2014)... Europe based upon a proxy for impact have been ... data, approach to scientific research. , The researchers from ... the top 100 pathogens affecting humans and the top ... believe, will help governments across the continent plan for ... as a result of climate change, and for biosecurity. ...
Breaking Biology News(10 mins):Law Enforcement Biometrics Market in North America 2014-2018 2Law Enforcement Biometrics Market in North America 2014-2018 3Law Enforcement Biometrics Market in North America 2014-2018 4Law Enforcement Biometrics Market in North America 2014-2018 5Pitt and Carnegie Mellon engineers discover why learning can be difficult 2Pitt and Carnegie Mellon engineers discover why learning can be difficult 3Big data approach identifies Europe's most dangerous human and domestic animal pathogens 2
... a new protein that plays a critical role in enabling ... or stress, as well as in the progressive loss of ... Their findings, they said, suggest new approaches to prevent or ... in the U.S. The team reports its findings in the ...
... a number of Weizmann Institute scientists have addressed ... such as proteins, have adapted to function in ... from halophilic (salt-loving) microorganisms from the Dead Sea. ... proteins, researchers were able to explain how these ...
... it has discovered a new class of orally-effective, ... Biota has filed worldwide patents and selected a ... further preclinical development prior to human clinical trials. ... and already a billion-dollar market, with growing visibility ...
Cached Biology News:Newly Discovered Role for Heart Response Enzyme May Yield Better Heart Failure Therapy 2Living with salt 2Biota makes major antiviral discovery 2
... Round Well Plate Sterile ... wide range of 384-well ... high-throughput screening and research. ... assays and are suitable ...
... thermostable DNA polymerase purified from the Thermus ... developed by Kaledin (1,2,3) for the isolation ... from thermophilic bacteria. Amplification of DNA fragments ... with this enzyme. The enzyme has both ...
HLA-DRbeta (DA2)...
... 5 / 6 Cytokeratin 5 (58 ... type of cytokeratin expressed in basal, the ... stratified epithelia as well as transitional epithelia, ... mesothelioma. Cytokeratin 6 (56 kD) is also ...
Biology Products: